The American people clearly spoke, and the drubbing Democrats received requires looking beyond just issue polls, voting patterns, campaign strategy, or get-out-the-vote tactics.
pharma mergers
Follow:
-
Why Are Drug Monopolies Running Amok? Meet Deborah Feinstein
After going back and forth through the revolving door, Feinstein heads the Federal Trade Commission’s Bureau of Competition, which has effectively abandoned all attempts to block Big Pharma mergers.